Conference call to discuss new data presented for duvakitug (Anti-TL1A) positive Phase 2b results at the 20th Annual Congress of the European ...

Teva Pharmaceuticals and Alvotech said on Friday they have launched a biosimilar to Johnson & Johnson's autoimmune drug Stelara in the United States, the second in a wave of near-copies of the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Investors with a lot of money to spend have taken a bearish stance on Teva Pharmaceutical Indus (NYSE:TEVA). And retail traders should know. We noticed this today when the trades showed up on ...

Looking ahead, revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 8.6% growth forecast for the Pharmaceuticals industry in the US.

The Rams are headed Down Under. It’s a year and a half away, but the Rams will be the home team for the NFL’s first regular-season game in Australia, the league announced Wednesday.

Teva Pharmaceutical (NYSE:TEVA) shares snapped six straight sessions of losses, as the stock closed 0.88% higher at $17.21 on Wednesday. The company lost over 20% in the preceding six sessions.

SYDNEY - Australia has banned DeepSeek AI services from all government systems and devices, becoming one of the first countries to take direct action against a Chinese artificial intelligence ...

Australia has banned DeepSeek from all government devices over concerns that the Chinese artificial intelligence startup behind it poses security risks, the government said Tuesday. The Secretary ...

Australia has banned DeepSeek from all government devices and systems over what it says is the security risk the Chinese artificial intelligence (AI) startup poses. DeepSeek stunned the world in ...